Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

CVX
B of A Securities Maintains Buy on Chevron, Raises Price Target to $227

B of A Securities Maintains Buy on Chevron, Raises Price Target to $227...

CRM
Why Is Salesforce Stock Surging Tuesday?

Why Is Salesforce Stock Surging Tuesday?...

AMZN
Apple, Microsoft, Meta, Amazon Earnings: Why The Next 48 Hours Could Redefine The AI Trade

Apple, Microsoft, Meta, Amazon Earnings: Why The Next 48 Hours Could Redefine The AI Trade...

STRL
Shares of data center infrastructure-related companies are trading lower as growth-oriented, AI-exposed stocks continue their retracement amid concerns over Chinese competition affecting the sector's hyperscaler clients and elevated Fed rates leading to costlier borrowing.

Shares of data center infrastructure-related companies are trading lower as growth-oriented, AI-exposed stocks continue their retracement amid concern...

BA
QUICK SPARK: Jim Cramer Says Boeing Stock Is 'Ready to Run'

QUICK SPARK: Jim Cramer Says Boeing Stock Is 'Ready to Run'...

USO
China Developments Spark KOSPI Crash, US Semi Stocks Follow As Fed Decision Looms

China Developments Spark KOSPI Crash, US Semi Stocks Follow As Fed Decision Looms...

META
Microsoft Could Swing $189 Billion in Value After Earnings

Microsoft Could Swing $189 Billion in Value After Earnings...

AAPL
Amazon, Apple, Meta, Microsoft Earnings on Deck: 33% of Benzinga Viewers Say This is Top Report to Watch

Amazon, Apple, Meta, Microsoft Earnings on Deck: 33% of Benzinga Viewers Say This is Top Report to Watch...

XLV
'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive

'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seni...

V
Visa Q3 Adj. EPS $3.32 Beats $3.23 Estimate, Sales $11.633B Beat $11.388B Estimate

Visa Q3 Adj. EPS $3.32 Beats $3.23 Estimate, Sales $11.633B Beat $11.388B Estimate...

V
Visa Reports $563M As Severance Expenses

Visa Reports $563M As Severance Expenses...

V
Visa Posts Strong Q3 Results: CEO Says 'Consumer and Business Spending Remains Resilient'

Visa Posts Strong Q3 Results: CEO Says 'Consumer and Business Spending Remains Resilient'...

$BTC
CLARITY Act Vote Delayed as Senate Turns to Russia Sanctions: What Do Prediction Markets Forecast?

CLARITY Act Vote Delayed as Senate Turns to Russia Sanctions: What Do Prediction Markets Forecast?...

INTC
B of A Securities Maintains Buy on Intel, Maintains $160 Price Target

B of A Securities Maintains Buy on Intel, Maintains $160 Price Target...

MSFT
'OpenAI's rogue agent compromised an account at a second tech firm, executive says'- Reuters Exclusive

'OpenAI's rogue agent compromised an account at a second tech firm, executive says'- Reuters Exclusive...

GS
QUICK SPARK: Goldman's High Beta Momentum Basket Heads for Worst Month Ever

QUICK SPARK: Goldman's High Beta Momentum Basket Heads for Worst Month Ever...

HIKMA
FDA Approves Unknown Drug — HIKMA

HIKMA Pharmaceuticals announced on Tuesday that the U.S. FDA approved its Abbreviated New Drug Application (ANDA 218728), signaling a positive pipelin...

Somerset
FDA Approves SUGAMMADEX — Somerset Therapeutics, LLC

Somerset Therapeutics has received FDA approval for the intravenous formulation of sugammadex, the antidote to rocuronium bromide, marking a pivotal e...

Hikma
FDA Approves SUGAMMADEX — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. announced on Friday the approval of sugammaDEX sodium for the intravenous treatment of hyperkalemia, securing a key FDA...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA INC

TEVA PHARMS USA INC announced the FDA approval of its ANDA application 214126, clearing the way for the launch of the generic version of the Blockbust...